Investor Presentaiton

☐ ☐ ☐ Unlocking value through win-win alliances Zydus Nycomed JV - most successful contract manufacturing JV in Indial State-of-the-art mfg. facility for Pantoprazole key intermediates Commissioned the expanded facility to manufacture complex high-end APIs for Nycomed Zydus Hospira - JV for oncology injectables State-of-the-art cytotoxic facility in SEZ - approved by MHRA, USFDA, TGA and Health Canada Plan to manufacture 6 oncology products Commercial supplies for EU market commenced Zydus BSV JV for oncology NDDS - State-of-the-art mfg. plant in SEZ near Ahmedabad Launched NDDS product in India as Nudoxa Strategic out-licensing deal with Abbott Labs To license 24 products for 15 key emerging markets Option to include 40 additional products Sales Contribution from JVs (Rs. Mio.) 2708 2152 ▲ 70% 1597 839 60% 999 758 556 FY 08-09 FY 09-10 FY 10-11 Zydus Nycomed Zydus Hospira 16

View entire presentation